NEW CLINICAL TRIALS AVAILABLE FOR MPN PATIENTS
Two new clinical trials available for MPN patients
Click here to learn more about current clinical trials for PV, ET, and MF patients.
This is a 2-tiered, Phase 2, Rule-based, Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib (TEW-7197) in the Treatment of Anemic Patients With Philadelphia Chromosome-negative MPNs (Ph-neg MPNs). Read the full description here
Status: Not yet recruiting
This is a Phase 1 cohort, dose-escalation study of PRT543 inpatients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose andschedule to be used in the development of PRT543.
Read the full